Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 265 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
Patents for C07D 265 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms (11,132)
10/2003
10/22/2003CN1125073C Process for preparing (-) pyridobenzoxazine carboxylic acid derviatives
10/21/2003US6635783 Bicyclic 1,3-aminoalcohols, d8-metal complexes and hydrogenation processes
10/21/2003US6635661 Heterocyclic analgesic compounds and methods of use thereof
10/21/2003US6635637 Cyclic oxyguanidine protease inhibitors
10/16/2003WO2003084938A2 Pyrimidone derivatives useful for the treatment of inflammatin and immunological diseases
10/16/2003WO2003084937A2 Pyrimidinedione derivatives useful for the treatment of inflammation and immunological diseases
10/16/2003WO2003084936A2 Amino substituted pyrimidinone derivatives useful in the treatment of inflammation and immunological
10/16/2003WO2003084935A2 Diaryl pyrimidinone derivatives useful for the treatment of inflammation and immunogolical diseases
10/16/2003WO2003084927A1 Haloalkenes, process for production thereof, and pest controllers containing the same
10/16/2003WO2003084917A1 (2-((2-alkoxy) -phenyl) -cyclopent-1-enyl) aromatic carbo and heterocyclic acid and derivatives
10/16/2003US20030195362 For therapy of retroviral infection and in particular an HIV infection
10/16/2003US20030195207 Treating bone disorders, osteoporosis, cardiovascular disorders; use as anticholesterol agent, animal growth agents, modulators of bone resorption; treating CNS disorder, hypertriglyceridemia, urogenital disorders, cancer
10/16/2003US20030195206 An enzyme inhibitors, enzyme is to catalyse the hydrolysis of an ester; treating hyperlipaemia, hyperglycaemia (type II diabetes), hypertension, cardiovascular disorders stroke, gastrointestinal disease; chemical intermediate synthesis
10/16/2003US20030195201 Vanilloid receptor ligands and their use in treatments
10/16/2003CA2481035A1 (2-((2-alkoxy) -phenyl) -cyclopent-1-enyl) aromatic carbo and heterocyclic acid and derivatives
10/15/2003EP1351959A1 Novel pleuromutilin derivatives
10/15/2003EP1351938A1 Phenyl derivatives
10/15/2003CN1448393A Novel dioxomorpholine for antiendoparasite
10/14/2003US6632814 Dihydro-benzo(1,4)oxazines
10/09/2003WO2003082862A1 Anti-inflammatory morpholin-acetamide derivatives
10/09/2003WO2003082837A1 Hydroxymorpholinone derivative and medicinal use thereof
10/09/2003WO2003082836A1 New dioxomorpholines for combating endoparasites
10/09/2003WO2003082835A1 Process for the preparation of morpholine derivatives and intermediates therefore
10/09/2003WO2003082834A2 Morpholine derivatives and intermediates therefor
10/09/2003WO2003082295A1 Morpholine derivatives substituted at the 2-position by a heterocyclylalkylurea group for use as ccr-3 antagonists in the treatment of inflammatory conditions
10/09/2003WO2003082294A1 Morpholine derivatives with a substituted acetamide group in the 2-position for use as ccr-3 antagonists for the treatment of inflammatory diseases
10/09/2003WO2003082293A1 Benzenesulphonate salt of a morpholine urea derivative for use as a ccr-3 antagonist in the treatment of inflammatory conditions
10/09/2003WO2003082292A1 Morpholine derivatives substituted at the 2-position by an arylalkylurea group for use as ccr-3 antagonists in the treatment of inflammatory conditions
10/09/2003WO2003082291A1 N-{´ (2s) -4- (3, 4-difluorobenzyl) morpholin-2yl!methyl} -2-{3-' (methylsulphonyl) amino! phenyl}acetamide as ccr3 antagonist for the treatment of inflammatory conditions
10/09/2003WO2003082190A2 Spirocyclic amides as cannabinoid receptor modulators
10/09/2003US20030191319 Alpha-and beta-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
10/09/2003US20030191123 2-amino-benzoxazinone derivatives for the treatment of obesity
10/09/2003US20030191118 Inhibitors of alpha4 mediated cell adhesion
10/09/2003US20030191106 Controlling gramnegative bacteria
10/09/2003CA2479912A1 Benzenesulphonate salt of a morpholine urea derivative for use as a ccr-3 antagonist in the treatment of inflammatory conditions
10/09/2003CA2479910A1 N-{ '(2s) -4- (3, 4-difluorobenzyl) morpholin-2yl]methyl} -2-{3-' (methylsulphonyl) amino] phenyl}acetamide as ccr3 antagonist for the treatment of inflammatory conditions
10/09/2003CA2479819A1 Process for the preparation of morpholine derivatives and intermediates therefore
10/09/2003CA2479618A1 Spirocyclic amides as cannabinoid receptor modulators
10/08/2003CN1123566C Arylsulfonyl hydroxamic acid derivatives
10/07/2003US6630503 Cell adhesion inhibitors
10/07/2003US6630165 For sustained release; therapy
10/02/2003WO2003080736A1 Use of oxazine dyes as marking groups for single molecule analysis
10/02/2003US20030187256 Benoxazinones/benzothiazinones as serine protease inhibitors
10/02/2003US20030186958 Viricides, vision defects, oral diseases, antiarthritic agents, multiple sclerosis, anticancer agents
10/02/2003US20030186349 Optical molecular sensors for cytochrome P450 activity
10/01/2003EP1021421B1 Amino- and hydroxysubstituted triphenyl-s-triazines as stabilizers
10/01/2003CN1122657C Colchicine skeleton compounds, their use as medicaments and compounds containing them
09/2003
09/30/2003US6627627 Aralkyl and aralkylidene heterocyclic lactams and imides
09/30/2003US6627111 Reduced pH sensitivity and enhanced stability to protonation; efficiency
09/25/2003WO2003078409A1 Carboxyoic acid compounds and drugs containing the compounds as the active ingredient
09/25/2003WO2003078376A1 Nk1 antagonists
09/25/2003US20030181441 Tumor necrosis factor-alpha converting enzyme antagonists, such as (2S,3S)-4-(4-(3,5-difluro-benzyloxy)-benzenesulfonyl) -2-methyl-thiomorpholine-3-carboxylic acid hydroxyamide, used as antiarthritic or anticarcinogenic agents
09/25/2003CA2479352A1 Carboxylic acid compound and a pharmaceutical agent comprising the compound as an active ingredient
09/25/2003CA2478211A1 Nk1 antagonists
09/24/2003EP1345889A1 Method for the regioselective preparation of substituted benzo g]quinoline-3-carbonitriles and benzo g]quinazolines
09/24/2003EP1345603A1 (halo-benzo carbonyl)heterocyclo fused phenyl p38 kinase inhibiting agents
09/24/2003CN1444570A Non-steroidal inflammation inhibitors
09/23/2003US6624189 Byrostatin analogues, synthetic methods and uses
09/23/2003US6624161 Administering 2-oxy substituted benzoxazin-5-one derivative to a human or animal for the prevention or treatment of obesity or an obesity related disorder
09/18/2003WO2003076639A1 Osteoclast differentiation inhibitors
09/18/2003WO2003076374A1 PROCESS FOR PRODUCING trans-4-AMINO-1-CYCLOHEXANECARBOXYLIC ACID DERIVATIVE
09/18/2003WO2003075915A1 5-}2-hydroxy-3-`1-(3-trifluoromethylphenyl)-cyclopropyl!-propionylamino}- phtalide and related compounds with progesterone receptor modulating activity for use in fertility control and hormone replacement therapy
09/18/2003US20030176670 Multivalent macrolide antibiotics
09/18/2003US20030176430 For therapy and prophylaxis of Tachykinin-mediated diseases
09/18/2003US20030176429 2-thio-4h-3,1-benzoxazin-4-one derivatives for use as enzyme inhibitors
09/18/2003US20030173251 Hydroxy aromatic mannich base condensation products and the use thereof as soot dispersants in lubricating oil compositions
09/18/2003CA2478948A1 5-}2-hydroxy-3-`1-(3-trifluoromethylphenyl)-cyclopropyl!-propionylamino}-phtalide and related compounds with progesterone receptor modulating a ctivity for use in fertility control and hormone replacement therapy
09/17/2003EP1344776A1 5- 2-hydroxy-3-[1-(3-trifluoromethylphenyl)-cyclopropyl]-propionylamino -phtalide and 6- 2-hydroxy-3-[1-(3-trifluoromethylphenyl)-cyclopropyl]-propionylamino -4-methyl-2,3-benzoxazin-1-one derivatives with progesterone receptor modulating activity for use in fertility control, hormone replacement therapy and the treatment of gynecological disorders
09/17/2003EP1133471B1 Hydrazine derivatives
09/17/2003CN1121398C Alicyclic acylated heterocyclic derivatives
09/16/2003US6620905 Curable compositions containing benzoxazine
09/16/2003US6620851 Methods for the treatment of neuropathic pain and other disorders using R(−)-ketoprofen
09/16/2003US6620809 Substituted (dihydro)benzoxazine and (dihydro)benzothiazine compounds
09/16/2003CA2068089C Method and compositions for using non-ionic contrast agents to reduce the risk of clot formulation in diagnostic procedures
09/12/2003WO2002058695A9 (halo-benzo carbonyl)heterocyclo fused phenyl p38 kinase inhibiting agents
09/12/2003CA2477728A1 Open-chain alkoxyamines and their corresponding nitroxides for controlled low temperature radical polymerization
09/11/2003WO2003074572A1 Open-chain alkoxyamines and their corresponding nitroxides for controlled low temperature radical polymerization
09/11/2003US20030171349 Novel muscarinic receptor agonists
09/11/2003US20030170381 Piezoelectric element and process for production thereof
09/10/2003EP1341775A2 Process for the preparation of morpholinones
09/10/2003EP1341755A1 Carboxylic acid amide derivatives and their use in the treatment of thromboembolic diseases and tumours
09/10/2003CN1441792A Silent mark for oil product and detection method thereto
09/04/2003WO2003072638A1 Curable compositions containing benzoxazine
09/04/2003WO2003072537A2 Selective protein tyrosine phosphatatase inhibitors
09/04/2003WO2003072055A2 Propargylamino indan derivatives and propargylamino tetralin derivatives as brain-selective mao inhibitors
09/04/2003US20030166650 E.g., 3-(2-fluorophenyl)-N-(1-(3-morpholin-4-yl)phenyl)-propyl)acrylamide; disorders responsive to opening of KCNQ potassium channels; analgesics; migraine, bipolar disorders, anticonvulsants, antiepileptic, anxiolytic agents
09/04/2003CA2477218A1 Propargylamino indan derivatives and propargylamino tetralin derivatives as brain-selective mao inhibitors
09/03/2003EP1340754A1 Substituted heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them
09/03/2003EP1339702A1 5-amide substituted diarylamines as mek inhibitors
09/03/2003EP1339696A1 Benzyl(idene)-lactams and their use as 5ht1-receptor ligands
09/03/2003EP0929533B1 4,4-disubstituted-1,4-dihydro-2h-3,1-benzoxazin-2-ones useful as hiv reverse transcriptase inhibitors and intermediates and processes for making the same
09/02/2003US6613791 N-substituted azaheterocyclic carboxylic acids and their use
09/02/2003US6613743 Sulfonamide inhibitors of aspartyl protease
08/2003
08/28/2003WO2003070709A1 Novel phenylalanine derivative
08/28/2003WO2003045315A3 Carbonylbenzoxazine compounds for enhancing glutamatergic synaptic responses
08/28/2003US20030162961 Catalytic carbonylation of three and four membered heterocycles
08/28/2003US20030162778 Carbocyclic side chain containing metalloprotease inhibitors
08/28/2003US20030162776 Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade
08/27/2003CN1119319C Asymmetric synthesis of (-) 6-chloro-4-cyclopropyl-ethynyl-4-trifluoromethyl-1, 4dihydro-2H-3, 1-benzoxazin-2-one
08/21/2003WO2003068212A1 Use of sodium/hydrogen exchange inhibitors from the treatment of thrombotic and inflammatory diseases
1 ... 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 ... 112